Rising UFC middleweight Kelvin Gastelum was expected to take on Anderson Silva at UFC 212 on June 3. Unfortunately on April 6, Gastelum was informed by the U.S. Anti-Doping Agency of a potential violation due to carboxy-tetrahydrocannabinol, which is known at THC.
UFC officials announced the potential failed test on their website.
Check out the full statement below:
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) informed Kelvin Gastelum of a potential Anti-Doping Policy violation involving Carboxy-Tetrahydrocannabinol (“Carboxy-THC”) which is a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, stemming from an in-competition sample collected in conjunction with his recent bout in Fortaleza, Brazil on March 11, 2017.